Weekly Update of Drug News-22/10/2025
On Oct 6 2025, AbbVie announced positive topline results from its Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) for upper limb essential tremor compared to placebo.
Updated on: October 22,2025
0
Weekly Update of Drug News-22/10/2025
On Oct 6 2025, AbbVie announced positive topline results from its Phase 2 ELATE trial evaluating onabotulinumtoxinA (BOTOX) for upper limb essential tremor compared to placebo.
Updated on:October 22,2025
0
